XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
FAIR VALUE MEASUREMENT
3 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
FAIR VALUE MEASUREMENT

Note 6 – FAIR VALUE MEASUREMENT

 

On February 8, 2024, in connection with the Warrant Exercise and Issuance, the Company estimated the aggregate fair value of the Existing Warrants (see Note 4 – Stockholders’ Equity for details) to be $1,115,334 using the Black-Scholes option pricing model (Level 3 inputs) and, accordingly, recognized a loss on the change in fair value of derivative liabilities of $12,999 during the three months ended March 31, 2024. The following table shows the detail of the valuation assumptions used:

   February 8, 2024 
Risk free interest rate   4.20 - 4.28%
Expected term (years)   2.75 - 2.76 
Expected volatility   102%
Expected dividends   0.00%

 

On February 8, 2024, the Company estimated the aggregate issuance date fair value of the derivative liability related to the New Warrants (see Note 4 – Stockholders’ Equity for details) as $2,189,420 using the Black-Scholes option pricing model (Level 3 inputs).

 

The following table shows the detail of the valuation assumptions used:

 

   February 8, 2024 
Risk free interest rate   4.12%
Expected term (years)   5.00 
Expected volatility   101%
Expected dividends   0.00%

 

On March 31, 2024, the Company estimated the aggregate fair value of warrants that are accounted for as derivative liabilities to be $2,755,358 using the Black-Scholes option price model (Level 3 inputs) and, accordingly, recognized a loss on the change in fair value of these derivative liabilities of $124,320 during the three months ended March 31, 2024. The following table shows the detail of the valuation assumptions used:

 

   March 31, 2024 
Risk free interest rate   4.21 - 4.22%
Expected term (years)   2.61 - 4.86 
Expected volatility   101%
Expected dividends   0.00%

 

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis during the three months ended March 31, 2024:

 

 

Balance, January 1, 2024 (as restated)  $1,543,953 
Issuance of warrants   2,189,420 
Exercise of warrants   (1,115,334)
Change in fair value of derivative liability   137,319 
Balance, March 31, 2024  $2,755,358 

 

Assets and liabilities measured at fair value on a recurring basis are as follows:

 

   Fair value measurements at reporting date using: 
   Quoted prices in active markets for identical liabilities (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3)   Total Fair Value 
Assets:                    
Marketable securities as of March 31, 2024  $15,261,220   $-   $-   $15,261,220 
Marketable securities as of December 31, 2023  $10,181,618   $-   $-   $10,181,618 
                     
Liabilities:                    
Derivative liabilities as of March 31, 2024  $-   $-   $2,755,358   $2,755,358 
Derivative liabilities as of December 31, 2023 (as restated)  $-   $-   $1,543,953   $1,543,953